Mannose-binding lectin gene polymorphisms in a cohort study of ANCA-associated small vessel vasculitis

Rheumatology

Volumn 46, Issue 7, 2007, Pages 1076-1078

  Kamesh, L ^a   Heward, J M ^a   Williams, J M ^a   Gough, S C L ^a   Savage, C O S ^a   Harper, L ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

ANCA; Auto antibody; Immunocompromised; Infection; Polymorphisms; Vasculitis

Indexed keywords

MANNOSE BINDING LECTIN;

ANCA ASSOCIATED VASCULITIS; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FISHER EXACT TEST; GENE FREQUENCY; GENETIC CODE; GENOTYPE; HUMAN; INCIDENCE; INFECTION; INFECTION RISK; INFECTION SENSITIVITY; LENGTH OF STAY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL VESSEL VASCULITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BACTERIAL INFECTIONS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHURG-STRAUSS SYNDROME; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MANNOSE-BINDING LECTIN; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RISK; STATISTICS, NONPARAMETRIC; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 34447319114     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem099     Document Type: Article

References (20)

1. Booth AD, Almond MK, Burns A et al. Outcome of ANCA-associated renal vasculitis: A 5-year retrospective study. Am J Kidney Dis 2003;41:776-84.
2. Harper L, Savage CO. ANCA-associated renal vasculitis at the end of the twentieth contury-a disease of older patients. Rheumatology 2005;44:495-501.
3. Madsen HO, Garred P, Thiel S et al. Interplay between promoter and structural gene variants control basal serum levell of mannan-binding protein. J Immunol 1995;155:3013-20.
4. Peterslund NA, Koch C, Jensenius JC, Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 2001;358:637-8.
5. Neth O, Hann I, Turner MW, Klein NJ. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: A prospective study. Lancet 2001;358:614-18.
6. Garred P, Madsen HO, Halberg P et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum 1999;42:2145-52.
7. Graudal NA, Madsen HO, Tarp U et al. The association of variant mannose-binding lectin genotypes with radiographic outcome in rheumatoid arthritis. Arthritis Rheum 2000;43:515-21.
8. Valdimarsson H, Vikingsdottir T, Bang P et al. Human plasma-derived mannose-binding lectin: A phase I safety and pharmacokinetic study. Scand J Immunol 2004;59:97-102.
9. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
10. Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods 2000;241:33-42.
11. de Groot K, Gross WL, Herlyn K, Reinhold-Keller E. Development and validation of a disease extent index for Wegener's granulomatosis. Clin Nephrol 2001;55:31-8.
12. Jagiello P, Gencik M, Aming L et al. New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes. Hum Genet 2004;114:468-77.
13. Esnault VL, Testa A, Audrain M et al. Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int 1993;43:1329-32.
14. Huang D, Giscombe R, Zhou Y, Lefvert AK. Polymorphisms in CTLA-4 but not tumor necrosis factor-alpha or interleukin 1beta genes are associated with Wegener's granulomatosis. J Rheumatol 2000;27:397-401.
15. Rocha V, Franco RF, Porcher R, Bittencourt H, Silva WA, Jr, Latouche A et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002;100:3908-18. Epub 2002 Jul 25.
16. Bergmann OJ, Christiansen M, Laursen I et al. Low levels of mannose-binding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induction therapy. Eur J Haematol 2003;70:91-7.
17. Kilpatrick DC, McLintock LA, Allan EK et al. No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy-related infections. Clin Exp Immunol 2003;134:279-84.
18. Klein NJ, Kilpatrick DC. Is there a role for mannan/mannose-binding lectin (MBL) in defence against infection following chemotherapy for cancer? Clin Exp Immunol 2004;138:202-4.
19. Roy S, Knox K, Segal S et al. MBL genotype and risk of invasive pneumococcal disease: A case-control study. Lancet 2002;359:1569-73.
20. Dahl M, Tybjaeng-Hansen A, Schnohr P, Nordestgaard BG. A population-based study of morbidity and mortality in mannose-binding lectin deficiency. J Exp Med 2004;199:1391-9.